Teflutixol (Lu 10-022): a new thioxanthene derivative with antipsychotic properties. A pilot study
A new thioxanthene derivative, teflutixol (Lu 10-022) has been administered for 4 weeks to 21 patients [12 schizophrenics, 6 patients with obsessive, compulsive neurosis (OCN), 2 patients with affective psychosis (AP), and one patient with paranoic reactions (PR)]. The maximum daily dose varied betw...
Saved in:
Published in | Acta psychiatrica Belgica Vol. 83; no. 4; p. 397 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Belgium
01.07.1983
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | A new thioxanthene derivative, teflutixol (Lu 10-022) has been administered for 4 weeks to 21 patients [12 schizophrenics, 6 patients with obsessive, compulsive neurosis (OCN), 2 patients with affective psychosis (AP), and one patient with paranoic reactions (PR)]. The maximum daily dose varied between 0.5 mg and 4 mg administered once in the morning. Fifteen of the patients received 1 mg or less daily. Based upon weekly assessments by the BPRS as well as a global evaluation all 4 groups showed a clear amelioration of the scores, and for both the schizophrenics and the patients with OCN this was highly significant [student's t (p less than 0.001)]. |
---|---|
ISSN: | 0300-8967 |